Table 1.
Case series reporting outcomes of PTNS in pelvic pain disorders.
| Study | Type | N | Women/men | Mean age (years) | Diagnosis | Mean variables | Success rate (%) | Follow-up (weeks) |
|---|---|---|---|---|---|---|---|---|
| McGuire et al.19 | R | 5 | – | – | IC | Subjective improvement | 80 | – |
| Van Balken et al.20 | P | 33 | 11/22 | 51 | Pelvic pain | VAS, McGill pain questionnaire, SF-36 | 42 | 12 |
| Kim et al.21 | P | 15 | 10/5 | 60 | Pelvic pain | VAS, GRA, IPSS | 30–60 | 12 |
| Kabay et al.22 | P | 45 | 0/45 | 37 | Pelvic pain | NIH-CPSI, VAS | 40–66 | 12 |
| Ragab et al.23 | P | 20 | 20/0 | 41 | IC (NIDDK criteria) | VAS, ICSI/ICPI, GRA | 10 | 12 |
| Sudol et al.24 | P | 16 | 16/0 | 49 | IC/BPS (SUFU criteria) | GRA, VAS, ICSI/ICPI, PUF | 30–70 | 12 |
GRA, Global Response Assessment scale; IC, interstitial cystitis; IC/BPS, interstitial cystitis/bladder pain syndrome; ICSI/ICPI, O’Leary-Sant Interstitial Cystitis Symptom and Problem Index Questionnaire; IPSS, International Prostate Symptoms Score; NIH-CPSI, National Institutes of Health Chronic Prostatitis Symptom Index; P, prospective; PUF, Pelvic Pain and Urgency/Frequency Patient Symptom Scale; R, retrospective; SF-36, 36-Item Short Form Health Survey questionnaire; VAS, Visual Analogue Scale for pain.